Prevalence of Gallstones Compared in Children With Different Intravenous Lipids

Judith Pichler1, Tom Watson, Kieran McHugh

  • 1*Department of Paediatric Gastroenterology, Great Ormond Street Hospital NHS Trust, London, UK †Department of Paediatric Nephrology and Gastroenterology, University Children's Hospital, University Clinics Vienna, Austria.

Insights

Hepatobiliary complications are common in children receiving long-term parenteral nutrition (PN). Using mixed lipid emulsions is associated with fewer biliary issues compared to pure soya lipid, making it the preferred choice for pediatric patients.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Clinical Nutrition

Background:

  • Biliary liver disease in children with intestinal failure on long-term parenteral nutrition (PN) has multiple causes.
  • Lipid formulations in PN are a significant risk factor for hepatobiliary complications.

Purpose of the Study:

  • To compare the prevalence and outcomes of gallstones and sludge in children receiving different types of intravenous lipids during PN.
  • To identify risk factors associated with hepatobiliary abnormalities in this patient population.

Main Methods:

  • A retrospective review of liver and biliary tract imaging and clinical data from 71 children (aged 3 months to 17 years) on PN for over 3 months.
  • Comparison of hepatobiliary abnormalities based on the types of intravenous lipids administered.

Main Results:

  • Hepatobiliary abnormalities, including gallstones and sludge, were detected in a significant proportion of children on PN.
  • The newer mixed lipid emulsion was associated with fewer hepatobiliary abnormalities compared to pure soya lipid.
  • Predictors for sludge included young age at PN initiation, absence of enteral feeding, and motility disorders with a stoma.

Conclusions:

  • Hepatobiliary pathology is a frequent occurrence in pediatric patients requiring long-term PN.
  • Mixed lipid emulsions demonstrate a lower incidence of biliary complications and are recommended as the primary lipid formulation for children on PN.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
507
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
863
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
362
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
877
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.9K